• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    More On AEZS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Aeterna Zentaris Inc. (AEZS)

    -NasdaqCM
    0.53 0.00(0.00%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.53
    Open:0.54
    Bid:0.50 x 11400
    Ask:0.54 x 9700
    1y Target Est:1.48
    Beta:2.63
    Next Earnings Date:N/A
    Day's Range:0.52 - 0.55
    52wk Range:0.48 - 1.54
    Volume:1,441,593
    Avg Vol (3m):1,602,140
    Market Cap:48.00M
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEZS

    Comparison

    Symbol% ChgMkt Cap
    AEZS 0.00%48.00M
    CELGUp 1.13%96.09B
    ENMD 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4,363.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.34
    Quarterly EPS Est (Mar-15) :-0.10
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback